Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
183
天
Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical Development
作者
Abigail Dirks; Sylviane de Viron; Kenneth McFarlane; Kenneth A. Getz展开收起
作者单位
1. Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Boston, USA; 2. Clue Points S.A, Louvain-la-Neuve, Belgium; 3. CluePoints Inc, King of Prussia, USA展开收起
44
天
Identifying and Deploying Benchmarks for Clinical Research at Sites
作者
Rida Momin; Laura Mangiarini; Alexandre Dias Tavares Costa; Carla Peacock; Emaad Shariff; Sara Noorain; Jennifer Preston; Sabah Attar展开收起
作者单位
1. Northern Care Alliance NHS Foundation Trust, Greater Manchester, UK; 2. Fondazione Penta ETS, Padova, Italy; 3. Instituto Carlos Chagas (ICC/Fiocruz Paraná), Rio de Janeiro, Brazil; 4. Innovate R Ltd., Manchester, UK; 5. Groundmark Learning, Leamington Spa, UK; 6. University of Liverpool, Liverpool, UK展开收起
104
天
Real-World Evidence for Drug Approvals: Moving Toward Greater Regulatory Clarity
作者
Tala H. Fakhouri; Rasika Kalamegham; Nicole Mahoney; Rose Purcell; Mike D’Ambrosio展开收起
作者单位
1. Parexel International, Maryland, USA; 2. Genentech, Washington, DC, USA; 3. Novartis, Rockville, USA; 4. Takeda, Washington, DC, USA展开收起
270
天
Therapeutic Horizon in Multiple Myeloma: Analysis of the Emerging Landscape of Clinical Trials
作者
Marina Alacoque Rodrigues; Cristiane Aparecida Menezes de Pádua; Paula Lana de Miranda Drummond; Jéssica Soares Malta; Adriano Max Moreira Reis展开收起
作者单位
1. College of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; 2. Fundação Ezequiel Dias, Belo Horizonte, Brazil展开收起
130
天
140
天
Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities—A TransCelerate Perspective
作者
James Whitehead; Rajesh Ghosh; Anna Monaco; Jackie Grissinger; Inessa Neyman; Tom Umrath; Clint Craun展开收起
作者单位
1. AstraZeneca, Newmarket, England, UK; 2. Genentech/Hoffman LaRoche Ltd., South San Francisco, USA; 3. Merck & Co., Inc., Rahway, USA; 4. Johnson & Johnson, New Brunswick, USA; 5. Pfizer Global Pharmaceuticals, New York, USA; 6. Novartis Pharmaceuticals Corporation, East Hanover, USA; 7. TransCelerate BioPharma Inc., West Conshohocken, USA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天